Novel Combination BMP7 and HGF Gene Therapy Instigates Selective Myofibroblast Apoptosis and Reduces Corneal Haze In Vivo-Reference-Cited by-同舟云学术

Novel Combination BMP7 and HGF Gene Therapy Instigates Selective Myofibroblast Apoptosis and Reduces Corneal Haze In Vivo

Published:2018-02-21 Issue:2 Volume:59 Page:1045
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Gupta Suneel¹²,Fink Michael K.¹²,Ghosh Arkasubhra³,Tripathi Ratnakar¹²,Sinha Prashant R.¹²,Sharma Ajay⁴,Hesemann Nathan P.¹⁵,Chaurasia Shyam S.¹²,Giuliano Elizabeth A.²,Mohan Rajiv R.¹²⁵

Affiliation:

1. Harry S. Truman Memorial Veterans' Hospital, Columbia, Missouri, United States

2. One-Health One-Medicine Ophthalmology and Vision Research Center, University of Missouri Columbia, Missouri, United States

3. GROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore, India

4. Chapman University School of Pharmacy, Irvine, California, United States

5. Mason Eye Institute, University of Missouri School of Medicine, Columbia, Missouri, United States

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manipulating mitochondrial pyruvate carrier function causes metabolic remodeling in corneal myofibroblasts that ameliorates fibrosis;Redox Biology;2024-09

2. Corneal fibrosis: From in vitro models to current and upcoming drug and gene medicines;Advanced Drug Delivery Reviews;2024-06

3. Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo;The Ocular Surface;2024-04

4. Synthesis, Characterization and Biosafety Evaluation of Hollow Gold Nanospheres;Current Pharmaceutical Biotechnology;2024-02

5. Manipulating Mitochondrial Pyruvate Carrier Function Causes Metabolic Remodeling in Corneal Myofibroblasts that Ameliorates Fibrosis;2024